Stock 000623 JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jilin Aodong Pharmaceutical Group Co., Ltd.

Equities

000623

CNE000000719

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
13.14 CNY +0.31% Intraday chart for Jilin Aodong Pharmaceutical Group Co., Ltd. -3.60% -13.21%
Jul. 04 Aodong Medicine Industry's Unit Gets Nod to Register 10 Chinese Traditional Medicines MT
Jul. 02 Jilin Aodong Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 09 July 2024 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 17,020 17,098 15,714 -
Enterprise Value (EV) 1 17,020 17,098 15,714 15,714
P/E ratio 10.2 x 12.3 x 6.77 x 5.97 x
Yield - - - -
Capitalization / Revenue - 4,957,303 x - -
EV / Revenue - 4,957,303 x - -
EV / EBITDA - 10,730,142 x - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 0.66 x - -
Nbr of stocks (in thousands) 1,135,395 1,129,349 1,195,895 -
Reference price 2 14.99 15.14 13.14 13.14
Announcement Date 4/18/23 4/16/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales - 3,449 - -
EBITDA - 1,593 - -
EBIT - 1,382 - -
Operating Margin - 40.08% - -
Earnings before Tax (EBT) - 1,500 - -
Net income 1 1,781 1,460 2,403 2,726
Net margin - 42.33% - -
EPS 2 1.467 1.227 1.940 2.200
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/18/23 4/16/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 5.48% - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - 22.80 - -
Cash Flow per Share - 0.0600 - -
Capex - 385 - -
Capex / Sales - 11.16% - -
Announcement Date 4/18/23 4/16/24 - -
1CNY in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.14
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JILIN AODONG PHARMACEUTICAL GROUP CO., LTD. Stock Jilin Aodong Pharmaceutical Group Co., Ltd.
-13.21% 2.17B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
PFIZER, INC. Stock Pfizer, Inc.
+0.45% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000623 Stock
  4. Financials Jilin Aodong Pharmaceutical Group Co., Ltd.